INO trade ideas
INO Head & Shoulder Patternbroke out of the descending Triangle, forming a bullish Head & Shoulders pattern. I see some short term resistances. Eventually we will have to re-test 07-08 hi.
INO bullish but in Stealth modescaling in biotech,$ ino looking very bullish but very selectively stealth like as in its under the radar and they trying to keep it that way.
Inovio pharm After the increase over the last 2weeks because of their HPV vaccine INO now forms lower highs and higher lows. while the MACD just crossed over the triggerline and RSI is relatively high (below 75 now but still high). i expect a short term decrease and a long term increase
INO, it has a long accumulation phrase for the last 2 years INO has a potential jump up ones again, but we have to note that there is one more dip down as it gets more fuel.
3.5.16 INO: Have we found a bottom?Upcoming earnings report, not expecting a great report.
Could it be the catalyst to reverse this downtrend?
MACD is looking good, and just witnessed first close above 200-day MA in months. Must hold.
Afraid we may see another dip below $7, unless those $7 calls set at 7 kick in.
$INO - Cup and Handle formation more and more clear. Chart trending above the two MAs is a very bullish move. The cup and handle formation is looking clearer every day.
Cup and Handle formation? $INOHere you can see a clean and classic formation of a cup. But where is the handle? That's what I'll be waiting for.
INO Public Offering Right On TimeOfferings are usually priced at short term peaks in the market. Watching to see how it acts from here but guessing it looks like dead money now
INOI still like that multi-year Inv H&S. Retail capitulation, still moving off that failed Triangle. Support on the 61.8 Fib from the 2 low, on the up trend channel, very oversold.
YES - There is still time catch the Mosta-move coming to Inovio As an update to my last chart on Inovio, (Which failed to reach the price targets within he time-frame suggested), I still am witness to extremely Bullish signals. Patience is certainly a key when investing in micro-cap bio-tech stocks.
Inovio maintains a robust pipeline, recently initiated a phase 1 DNA immunotherapy trial for breast, lung and pancreatic cancers, is actively seeking partnership(s) for their ongoing trials and will be presenting detailed analysis of their recently completed phase 2 cervical dysplasia trial in the near future.
My current chart (I believe) shows that "the market" has gained much interest and is awaiting the many possible catalysts that will develop over the next several months.
6 month price target - $12.40 -- 12 month price target $21.00
INO Losing Momentum Since Roche Collaboration Termination On watch to determine direction, notes on chart give possible long and short possibilities
